​

Nurix Therapeutics (NRIX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Nurix Therapeutics Revenue Highlights

Latest Revenue (Y)

$54.55M

Latest Revenue (Q)

$7.89M

Main Segment (Y)

Collaboration Revenue

Nurix Therapeutics Revenue by Period

Nurix Therapeutics Revenue by Year

DateRevenueChange
2024-11-30$54.55M-29.15%
2023-11-30$76.99M99.31%
2022-11-30$38.63M29.84%
2021-11-30$29.75M66.95%
2020-11-30$17.82M-42.73%
2019-11-30$31.11M-16.91%
2018-11-30$37.45M-

Nurix Therapeutics generated $54.55M in revenue during NA 2024, up -29.15% compared to the previous quarter, and up 175.31% compared to the same period a year ago.

Nurix Therapeutics Revenue by Quarter

DateRevenueChange
2025-08-31$7.89M-82.08%
2025-05-31$44.06M138.75%
2025-02-28$18.45M38.91%
2024-11-30$13.28M5.53%
2024-08-31$12.59M4.10%
2024-05-31$12.09M-27.09%
2024-02-29$16.59M9.41%
2023-11-30$15.16M-17.91%
2023-08-31$18.47M-39.80%
2023-05-31$30.68M141.83%
2023-02-28$12.69M87.01%
2022-11-30$6.78M-37.14%
2022-08-31$10.79M-5.61%
2022-05-31$11.43M18.82%
2022-02-28$9.62M30.08%
2021-11-30$7.40M-27.86%
2021-08-31$10.25M44.58%
2021-05-31$7.09M41.51%
2021-02-28$5.01M-25.09%
2020-11-30$6.69M63.75%
2020-08-31$4.08M-2.32%
2020-05-31$4.18M46.02%
2020-02-29$2.86M53.81%
2019-11-30$1.86M-82.40%
2019-08-31$10.58M12.09%
2019-05-31$9.44M2.22%
2019-02-28$9.23M-

Nurix Therapeutics generated $7.89M in revenue during Q3 2025, up -82.08% compared to the previous quarter, and up 65.28% compared to the same period a year ago.

Nurix Therapeutics Revenue Breakdown

Nurix Therapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceNov 24Nov 23
Collaboration Revenue$54.55M$56.99M
License Revenue-$20.00M

Nurix Therapeutics's latest annual revenue breakdown by segment (product or service), as of Nov 24: Collaboration Revenue (100.00%).

Quarterly Revenue by Product

Product/ServiceAug 25May 25Nov 24Aug 24May 24Nov 23Aug 23May 23
Collaboration Revenue$7.89M$14.06M$29.87M$12.59M$12.09M$27.84M$18.47M$10.68M
License Revenue-$30.00M------

Nurix Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Aug 25: Collaboration Revenue (100.00%).

Nurix Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
IOVAIovance Biotherapeutics$164.07M$49.32M
DAWNDay One Biopharmaceuticals$131.16M$33.91M
URGNUroGen Pharma$90.40M$20.25M
NRIXNurix Therapeutics$54.55M$7.89M
MGTXMeiraGTx$33.28M$1.93M
ABSIAbsci$4.53M$593.00K
KODKodiak Sciences--
OLMAOlema Pharmaceuticals--
TERNTerns Pharmaceuticals--
ERASErasca--
OMEROmeros--

NRIX Revenue FAQ

What is Nurix Therapeutics’s yearly revenue?

Nurix Therapeutics's yearly revenue for 2024 was $54.55M, representing a decrease of -29.15% compared to 2023. The company's yearly revenue for 2023 was $76.99M, representing an increase of 99.31% compared to 2022. NRIX's yearly revenue for 2022 was $38.63M, representing an increase of 29.84% compared to 2021.

What is Nurix Therapeutics’s quarterly revenue?

Nurix Therapeutics's quarterly revenue for Q3 2025 was $7.89M, a -82.08% decrease from the previous quarter (Q2 2025), and a -37.29% decrease year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $44.06M, a 138.75% increase from the previous quarter (Q1 2025), and a 264.34% increase year-over-year (Q2 2024). NRIX's quarterly revenue for Q1 2025 was $18.45M, a 38.91% increase from the previous quarter (Q4 2024), and a 11.26% increase year-over-year (Q1 2024).

What is Nurix Therapeutics’s revenue growth rate?

Nurix Therapeutics's revenue growth rate for the last 3 years (2022-2024) was 41.22%, and for the last 5 years (2020-2024) was 206.11%.

What are Nurix Therapeutics’s revenue streams?

Nurix Therapeutics's revenue streams in v 24 are Collaboration Revenue

What is Nurix Therapeutics’s main source of revenue?

For the fiscal year ending Nov 24, the largest source of revenue of Nurix Therapeutics was Collaboration Revenue. This segment made a revenue of $54.55M, representing 100.00% of the company's total revenue.